Prognostic value of a whole body FDG PET vs conventional imaging for the evaluation of biologic therapy in renal cell carcinoma.

被引:0
|
作者
Hoh, CK [1 ]
Figlin, RA [1 ]
Seltzer, MA [1 ]
Belldegrun, A [1 ]
Franklin, J [1 ]
Gitliz, B [1 ]
Phelps, ME [1 ]
Maddahi, J [1 ]
机构
[1] UNIV CALIF LOS ANGELES,SCH MED,LOS ANGELES,CA
关键词
D O I
暂无
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
引用
收藏
页码:546 / 546
页数:1
相关论文
共 50 条
  • [31] Prognostic value of whole body FDG PET in breast cancer patients undergoing chemotherapy.
    Hoh, CK
    Chap, L
    Glaspy, JA
    Bui, S
    Czernin, J
    Phelps, ME
    JOURNAL OF NUCLEAR MEDICINE, 1998, 39 (05) : 254P - 254P
  • [32] Prognostic Significacne of MTORC1 Immunoexpression in Clear Cell (Conventional) Renal Cell Carcinoma.
    Kapur, P.
    Rakheja, D.
    Yousse, R. F.
    Margulis, V.
    Kabbani, W.
    Lotan, Y.
    MODERN PATHOLOGY, 2011, 24 : 202A - 203A
  • [33] Prognostic value of 18F-FDG PET/MR imaging biomarkers in oesophageal squamous cell carcinoma
    Yu, Chih-Wei
    Chen, Xin-Jia
    Lin, Yen-Heng
    Tseng, Yao-Hui
    Lu, Ching-Chu
    Chen, Bang-Bin
    Wei, Shwu-Yuan
    Lee, Jang-Ming
    Shih, Tiffany Ting-Fang
    EUROPEAN JOURNAL OF RADIOLOGY, 2019, 120
  • [34] The potential clinical value of FDG-PET for recurrent renal cell carcinoma
    Nakatani, Koya
    Nakamoto, Yuji
    Saga, Tsuneo
    Higashi, Tatsuya
    Togashi, Kaori
    EUROPEAN JOURNAL OF RADIOLOGY, 2011, 79 (01) : 29 - 35
  • [35] Small cell carcinoma of the parotid gland:: Evaluation with FDG PET Imaging
    Chander, S
    Ergün, EL
    Westphal, S
    Powell, W
    Zerin, JM
    Nandkumar, U
    CLINICAL NUCLEAR MEDICINE, 2004, 29 (08) : 502 - 503
  • [36] Role of 18F FDG PET imaging in management of small cell lung carcinoma.
    Pandit-Taskar, N
    Soler, M
    Krug, L
    Gonen, M
    Larson, SM
    JOURNAL OF NUCLEAR MEDICINE, 2001, 42 (05) : 74P - 74P
  • [37] Comparison of stereotactic body radiotherapy and conventional external beam radiotherapy in renal cell carcinoma.
    Tinkle, Christopher L.
    Shiao, Stephen Lawrence
    Weinberg, Vivian K.
    Lin, Amy M.
    Gottschalk, Alexander R.
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (07)
  • [38] FDG PET/CT as an imaging biomarker for patients with metastatic renal cell carcinoma
    Nakaigawa, N.
    Yao, M.
    Minamimoto, R.
    Namura, K.
    Makiyama, K.
    Ueno, D.
    Sakata, A.
    Kasuga, J.
    Inoue, T.
    Kubota, Y.
    EJC SUPPLEMENTS, 2010, 8 (07): : 195 - 196
  • [39] The Prognostic Value of Pretreatment FDG PET/CT in Patients with Oropharyngeal Squamous Cell Carcinoma
    Jensen, J. Schmidt
    Christensen, J. T.
    Hakansson, K. E.
    Zamani, M.
    Vogelius, I.
    Lofgren, J.
    Fischer, B. M.
    Friborg, J. T.
    Buchwald, C. V.
    Rasmussen, J. H.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2020, 106 (05): : 1165 - 1165
  • [40] FDG PET/CT as a survival prognostic factor in patients with advanced renal cell carcinoma
    Pankowska, Violetta
    Malkowski, Bogdan
    Wedrowski, Mateusz
    Wedrowska, Ewelina
    Roszkowski, Krzysztof
    CLINICAL AND EXPERIMENTAL MEDICINE, 2019, 19 (01) : 143 - 148